Bacteria and Their Relationship to Allergic Diseases;Bakterie a Jejich Vztah k Alergickỳm Onemocněním

Casopis Lekaru Ceskych

Volumn 143, Issue 1, 2004, Pages 21-25

  Humlová, Zuzana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Allergy; Asthma; Atopic dermatitis; Bacteria

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; BACTERIUM LIPOPOLYSACCHARIDE; BCG VACCINE; ENTEROTOXIN; FAS ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; MYCOBACTERIUM ANTIGEN; PROBIOTIC AGENT; STAPHYLOCOCCUS PROTEIN A; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TOXIC SHOCK SYNDROME TOXIN 1; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC DISEASE; ALLERGIC REACTION; ANTIGEN PRESENTING CELL; ASTHMA; ATOPIC DERMATITIS; B LYMPHOCYTE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CPG ISLAND; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INTESTINE FLORA; NATURAL KILLER CELL; REVIEW; TH1 CELL; TH2 CELL;

BACTERIA; HUMANS; HYPERSENSITIVITY; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS;

EID: 0842343511     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Johansson, S. G., Hourahine, J., Bousquet, J. et al.: A revised nomenclature for allergy. An EAACI position statement from EAACI nomenclature task force. Allergy, 2001, 56, s. 813-824.
2. Barnes, K. C.: Evidence for common genetics elements in allergic disease. J. Allergy Clin. Immunol., 2000, 106, s. 192-200.
3. Renz, H., Herz, U.: The bidirectional capacity of bacterial antigens to modulate allergy and asthma. Eur. Respir. J., 2002, 19, s. 158-171.
4. Prokešová, L., Součková, A.: Grampozitivní koky. In: Bednář, M., Souček, A., Vávra, J. Lékařská speciální mikrobiologie a parazitologie. Praha, Triton, 1994, s. 23-25.
5. Saloga, J., Knop, J.: Superantigens in skin diseases. Europ. J. Dermatol., 1999, 7, s. 586-590.
6. Bunikowski, R., Mielke, M., Skarabis, H. et al.: Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J. Allergy Clin. Immunol., 1999, 103, s. 119-124.
7. Breuer, K., Wittmann, M., Bosche, B. et al.: Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy, 2000, 55, s. 551-555.
8. Schlaak, J. F., Nieder, P., Meyer zum Buschenfelde, K. H., Fleischer, B.: et al.: Human T helper cells reactive with somatic bacterial antigens belong to the Th1 subset. Med. Microbiol. Immunol. (Berl.), 1994, 183, s. 169-175.
9. Shirakawa, T., Enomoto, T., Shimazu, S., Hopkin, J. M.: The inverse association between tuberculin responses and atopic disorder. Science, 1997, 275, s. 77-79.
10. Aaby, P., Shaheen, S. O., Heyes, C. B. et al.: Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin. Exp. Allergy., 2000, 30, s. 644-650.
11. Strannegard, I. L., Larsson, L. O., Wennergren, G., Strannegard, O.: Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy, 1998, 53, s. 249-254.
12. Zuany-Amorim, C., Sawicka, E., Manlius, C. et al.: Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nature Med., 2002, 6, s. 625-629.
13. Arkwright, P. D., David, T. J.: Intradermal administration of a killed Mycobacterium vaccae suspension (SRL172) is associated with improvement in atopic dermatitis in children with moderate-to-severe-disease. J. Allergy Clin. Immunol., 2001, 107, s. 531-534.
14. Yépez, S. H., Pando, R. H., Argumedo, L. S. et al.: Therapeutic efficcy of an E. coli strain carrying an ovalbumin allergenic peptide as a fused protein to OMPC in a murine model of allergic airway inflammation. Vaccine, 2003, 21, s. 566-578.
15. Ferenčík, M., Ebringer, L.: Možnosti využitia probiotík v prevencii a terapii alergických chorôb. Alergie, 2002, 1, s. 48-54.
16. Hanifin, J. M.: Epidemiology of atopic dermatitis. Monogr. Allergy, 1987, 21, s. 116-131.
17. Krieg, A. M.: CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol., 2002, 20, s. 709-760.
18. Ballas, Z. K., Rasmussen, W. L., Krieg, A. M.: Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol., 1996, 157, s. 1840-1845.
19. Krug, A., Rothenfusser, S., Hornung, V. et al.: Identification od CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Europ. J. Immunol., 2001, 31, s. 2154 až 2163.
20. Yi, A. K., Klinman, D. M., Martin, T. L. et al.: Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol., 1996, 157, s. 5394-5402.
21. Yi, A. K., Chang, M., Peckham, D. W. et al.: CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J. Immunol., 1998, 160, s. 5898-5906.
22. Kadowaki, N., Ho, S., Antonenko, S. et al.: Subset of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med., 2001, 194, s. 863-870.
23. Kline, J. N., Waldschmidt, T. J., Businga, T. R. et al.: Modulation of airway inflammation by CpG oligodeoxyribonucleotides in murine model of asthma. J. Immunol., 1998, 160, s. 2555-2559.
24. Glover, J. M., Leeds, J. M., Mant, T. G. et al.: Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302). J. Pharmacol. Exp. Ther., 1997, 282, s. 1173-1180.
25. Renz, H., Herz, U.: The bidirectional capacity of bacterial antigens to modulate allergy and asthma. Eur. Respir. J., 2002, 19, s. 158-171.
26. Baldini, M., Lohman, I. C., Halonene, M. et al.: A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell. Mol. Biol., 1999, 20, s. 976-983.
27. Tulic, M. K., Wale, J. L., Holt, P. G., Sly, P. D.: Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am. J. Respir. Cell. Mol. Biol., 2000, 22, s. 604 až 612.
28. Slater, J. E., Paupore, E. J., Elwell, M. R., Truscott, W.: Lipopolysaccharide augments IgG and IgE responses of mice to the latex allergen Hev b 5. J. Allergy Clin. Immunol., 1998, 102, s. 977-983.
29. Yazdanbakhsh, M., Kremsner, P. G., van Ree, R.: Allergy, parasites, and the hygiene hypothesis. Science, 2002, 296, s. 490-494.
30. Maloy, K. J., Powrie, F.: Regulatory T cells in the control of immune pathology. Nature Immunol., 2001, 2, s. 816-822.